Acta Cryst. (2012). C68, o488-o491 [ doi:10.1107/S0108270112045866 ]
Abstract: The combination of the active pharmaceutical ingredients furosemide [4-chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid] and pentoxifylline [3,7-dimethyl-1-(5-oxohexyl)-3,7-dihydro-1H-purine-2,6-dione] produces a 1:1 cocrystal, C12H11ClN2O5S·C13H18N4O3, (I), a 1:1 cocrystal hydrate, C12H11ClN2O5S·C13H18N4O3·H2O, (II), and a 1:1 cocrystal acetone solvate, C12H11ClN2O5S·C13H18N4O3·C2H6O, (III). These structures exhibit the presence of a rarely encountered synthon with the graph set R22(7). All potential hydrogen-bond donors of furosemide participate in hydrogen-bond formation in (I)-(III). However, only two hydrogen-bond acceptors of furosemide are active in (I) and (II), and only one is active in (III). Four hydrogen-bond acceptors of pentoxifylline are active in (II), three in (I) and two in (III). These observations are in good agreement with the calculated packing indexes of 69.5, 69.6 and 68.8% for (II), (I) and (III), respectively.
Formula: C12H11ClN2O5S·C13H18N4O3, C12H11ClN2O5S·C13H18N4O3·H2O and C12H11ClN2O5S·C13H18N4O3·C2H6O
Structure factor file (CIF format) (300.2 kbytes)
Structure factor file (CIF format) (314.6 kbytes)
Structure factor file (CIF format) (344.7 kbytes)
To open or display or play some files, you may need to set your browser up to use the appropriate software. See the full list of file types for an explanation of the different file types and their related mime types and, where available links to sites from where the appropriate software may be obtained.
The download button will force most browsers to prompt for a file name to store the data on your hard disk.
Where possible, images are represented by thumbnails.
Copyright © International Union of Crystallography